By Amanda Bronstad | January 9, 2018
The federal judge overseeing about 200 opioid lawsuits ordered lawyers into private talks on Tuesday with one goal in mind: find a way to settle the cases, and quickly.
By Amanda Bronstad | January 8, 2018
Lawyers who scored verdicts of $140 million and $150 million last year in the first trials over low testosterone medications have switched lead counsel for a trial that begins on Monday.
By Amanda Bronstad | January 4, 2018
A federal judge has approved a plaintiffs leadership team in the opioid litigation that's expected to get bigger—much bigger.
By Andrew Denney | December 27, 2017
Evan Greebel, a former partner at Katten Muchin Rosenman who was at Kaye Scholer at the time of his arrest, was stone faced as a jury handed up guilty verdicts for one count of conspiracy to commit wire fraud and one count of conspiracy to commit securities fraud.
National Law Journal | Analysis
By Amanda Bronstad | December 21, 2017
Opioids and data breaches are expected to be the hot mass torts in 2018, with tort reform expected to resurface on Capitol Hill.
By Amanda Bronstad | December 20, 2017
A group of more than 20 lawyers who would be on many observers' list of the “best and the brightest” of the mass torts bar filed a motion on Wednesday to be appointed lead counsel in the national opioid multidistrict litigation.
By Amanda Bronstad | December 5, 2017
A federal judicial panel has ordered nearly 180 government lawsuits filed against opioid manufacturers and distributors to be transferred to a judge in Ohio.
By Kristen Rasmussen | December 5, 2017
Federal regulators are likely to take a sharp eye to CVS Health's planned takeover of Aetna Inc., given the size of the consolidation within the health care industry, corporate lawyers say.
By Kristen Rasmussen | November 17, 2017
Dr. John Kapoor, the owner of Insys Therapeutics Inc., maker of a potent opioid medication, pleaded not guilty to federal bribery and racketeering charges on Thursday and asked the magistrate judge to remove his electronic monitoring bracelet.
By Mike Scarcella | November 16, 2017
A Wilmer Cutler Pickering Hale and Dorr counsel in Washington who specializes in regulatory and government affairs plans to divest interests in six major U.S. companies if he's confirmed to lead enforcement and compliance efforts at the U.S. Commerce Department. Kessler said in his ethics agreement he would divest holdings in Bristol-Myers Squibb Co., Ford Motor Co., JPMorgan Chase & Co., Microsoft Corp., Walt Disney Co. and Zimmer Biomet within 90 days of his confirmation.
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
With bold growth in recent years, Fox Rothschild brings together 1,000 attorneys coast to coast. We offer the reach and resources of a natio...
About Us:Monjur.com is a leading provider of contracts-as-a-service for managed service providers, offering tailored solutions to streamline...
Dynamic Boutique law firm with offices in NYC, Westchester County and Dutchess County, is seeking a mid level litigation associate to work ...